Current Role of Robotic Hysterectomy.
Background:While robotic surgery for gynecologic indications received U.S. government approval in 2005, and has been rapidly and widely adopted, it is currently unclear how often this approach to hysterectomy is utilized.Objective:The aim of this research was to assess length of stay (LOS), mortality, indications, and current use of robotic hysterectomy, compared to other types of hysterectomy.Methods:A retrospective study of hysterectomies performed in New York State (NYS) in 2011 was performed. Data, including indication for surgery, age, procedure, LOS, and discharge status were obtained from the NYS Department of Health Statewide Planning and Research Cooperative System (SPARCS).Outcome Measures:LOS and mortality rate, were calculated according to institution, procedure, and indication for surgery.Results:For 22073 hysterectomies performed in NYS, the mean LOS was 2.9 days, and there were 29 (0.13%) deaths. The mean LOS for abdominal (12774 cases, 3.9 days) hysterectomies was longer than for laparoscopic (3927 cases, 1.6 days), robotic (2814 cases, 1.6 days), or vaginal (2558 cases, 1.7 days) hysterectomies (p<0.05). The adjusted mortality rates for abdominal (0.20%), laparoscopic (0.03%), robotic (0.07%), and vaginal (0.04%) hysterectomies were not significantly different. Overall, robotic surgery was performed in 29% of hospitals, by 11% of physicians and in 13% of cases. A robotic approach was utilized in 35% of patients with uterine cancer, 13% with endometriosis, 11% with excessive bleeding, 8% with leiomyomata, and 8% with pelvic relaxation.Conclusions:Despite the advantages in reduced LOS for robotic and other minimally invasive types of hysterectomies, the abdominal route is still predominant in most institutions. (J GYNECOL SURG XX:1).
Division of Gynecologic Oncology, University of Rochester Medical Center , Rochester, NY.
Brent
B
Dubeshter
Division of Gynecologic Oncology, University of Rochester Medical Center , Rochester, NY.
Cynthia
C
Angel
Division of Gynecologic Oncology, University of Rochester Medical Center , Rochester, NY.
Eugene
E
Toy
Division of Gynecologic Oncology, University of Rochester Medical Center , Rochester, NY.
Sajeena
S
Thomas
Department of Obstetrics & Gynecology, University of Rochester Medical Center , Rochester, NY.
J Christopher
JC
Glantz